Regular Article
Oncogene amplification in solid tumors

https://doi.org/10.1006/scbi.1999.0126Get rights and content

Abstract

The term gene amplification refers to the selective increase of the gene copy number and is better designated as DNA amplification. It should not be confused with elevated gene expression, although amplification generally does result in enhanced levels of the products encoded by the amplified gene. Amplification is one of the mechanisms by which cells can meet the demand for synthesis of specific gene products in amounts exceeding the transcriptional capacity of a single copy gene. Cytogenetic studies of human and animal tumor cells have provided evidence for mysterious chromosomal abnormalities including double minutes (DMs), C–bandless chromosomes (CMs) or homogeneously staining chromosomal regions (HSRs) diagnostic for amplified DNA. MYCN has been the first oncogene found amplified in direct preparations of solid tumors, the group of oncogenes undergoing amplification has considerably expanded since. Today amplification of oncogenes is recognized as a major player in the development of many solid tumors in humans and at the same time is a reflection of the genetic instability of solid tumor cells.

References (47)

  • M Schwab et al.

    N-MYC oncogene amplification: A consequence of genomic instability in human neuroblastoma

    The Neuroscientist

    (1995)
  • M Schwab

    Amplification of oncogenes in human cancer cells

    BioEssays

    (1998)
  • M Schwab et al.

    Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer

    Genes Chromosomes Cancer

    (1990)
  • R Corvi et al.

    Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma

    Oncogene

    (1995)
  • M Schwab et al.

    Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor

    Nature

    (1983)
  • R Corvi et al.

    Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells

    Cancer Res

    (1995)
  • LC Amler et al.

    Amplified MYCN in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA

    Mol Cell Biol

    (1989)
  • LC Amler et al.

    The DDX1 gene maps wit hin 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastomas

    Genes Chromosomes Cancer

    (1996)
  • S Godbout et al.

    Amplification of a DEAD box protein in retinoblastoma cell lines

    Proc Natl Acad Sci USA

    (1993)
  • W Lutz et al.

    In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells

    Oncogene

    (1997)
  • M Schwab et al.

    Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma

    Proc Natl Acad Sci USA

    (1984)
  • RC Seeger et al.

    Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastoma

    N Engl Med

    (1985)
  • H Rubie et al.

    N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique

    J Clin Oncol

    (1997)
  • Cited by (170)

    • Small nucleolar RNAs in cancer

      2012, Biochimica et Biophysica Acta - Reviews on Cancer
      Citation Excerpt :

      Gene amplification is a major mechanism allowing for increased expression of oncogenes that contribute to cancer development and progression [105]. Interestingly, snoRA42 is located in 1q22, a frequent genomic amplified region observed in a variety of solid tumors, including non-small cell lung cancer (NSCLC) [61,62,106]. Furthermore, snoRA42 resides in intron 10 of KIAA0907.

    View all citing articles on Scopus

    Unspecified

    View full text